Menu
Search Close

News

Director Share Dealing

21st October 2013

The Company has been notified that on 21 October 2013 Lindy Durrant and Richard Goodfellow each sold 100,000 shares in the Company from their respective holdings held jointly with Scancell Employee Benefit Trust at a price of 30 pence per share.

Following these transactions their holdings in the Company are as follows:

 

Director Name

No. of shares held in own sole name post transaction

 

No. of shares held jointly with Scancell Employee Benefit Trust post transaction

 

Lindy Durrant

1,606,960

 

8,773,960

Richard Goodfellow

200,000

 

6,343,840

 

For Further Information:

 

Scancell Holdings Plc 

+ 44 (0) 20 7831 3113 

Dr Richard Goodfellow, Joint CEO 

 

Professor Lindy Durrant, Joint CEO 

 

 

 

Cenkos Securities plc:

+44 (0) 20 7397 8900

Camilla Hume

 

Stephen Keys

 

 

 

FTI Consulting

+44 (0) 20 7831 3113

Simon Conway

 

Mo Noonan

 

 

 

Dr. Reuter Investor Relations

+(0) 49 251 980 1561

Kim von Ahn

 

Webcasts, Interviews and Media Coverage

Scancell Holdings wins Japanese patent protection

It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia

Mon, 08 Apr 2019 08:20:00

Scancell strengthens IP with two “important” patent grants in US and Europe

The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88

Wed, 20 Mar 2019 07:55:00

Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise

The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise

Tue, 12 Feb 2019 15:07:00